v3.25.3
Fair Value of Non-marketable Equity Securities
 9 Months Ended
Oct. 26, 2025
Fair Value Disclosures [Abstract]  
Fair Value of Non-marketable Equity Securities Fair Value of Non-marketable Equity Securities
Our non-marketable equity securities are recorded in long-term other assets on our Condensed Consolidated Balance Sheets and valued under the measurement alternative. Gains and losses on these investments, realized and unrealized, are recognized in Other income, net on our Condensed Consolidated Statements of Income.
Adjustments to the carrying value of our non-marketable equity securities during the third quarter and first nine months of fiscal years 2026 and 2025 were as follows:
Three Months EndedNine Months Ended
Oct 26, 2025Oct 27, 2024Oct 26, 2025Oct 27, 2024
(In millions)
Balance at beginning of period$3,799 $1,819 $3,387 $1,321 
Adjustments related to non-marketable equity securities:
Net additions3,704 409 4,652 830 
Unrealized gains758 23 1,088 115 
Reclassification (1)
— — (848)— 
Impairments and unrealized losses(74)(14)(92)(29)
Balance at end of period$8,187 $2,237 $8,187 $2,237 
(1) Represents reclassifications from non-marketable equity securities to marketable securities following public market trading.
Non-marketable equity securities had cumulative gross unrealized gains of $1.4 billion and $374 million, and cumulative gross unrealized losses and impairments of $167 million and $74 million on securities held as of October 26, 2025 and October 27, 2024, respectively.